Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Medicine, Internal medicine, Artificial intelligence, Computer science, Selumetinib, and KRAS.
The Use of Artificial Intelligence for Cancer Therapeutic Decision-Making
Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non–Small Cell Lung Cancer: Real-World Analysis of Select ASCO- <i>Friends</i> Recommendations
Artificial intelligence and machine learning in clinical development: a translational perspective
Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer
Two parallel randomized phase II studies of selumetinib (S) and erlotinib (E) in advanced non-small cell lung cancer selected by KRAS mutations.